Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-DOCT: Bevacizumab with Chemotherapy in Advanced Gastric Cancer
NCT01359397Phase 2Unknown
- Sponsor
- Netherlands Cancer Institute
- Start
- Mar 2011
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Netherlands Cancer Institute. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01359397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01359397.